NAPG expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63213886850144E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.43867165245138E-13 |
Normal-vs-Stage2 |
7.09429999967703E-07 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
6.201200E-01 |
Stage1-vs-Stage3 |
3.104900E-03 |
Stage1-vs-Stage4 |
1.032330E-04 |
Stage2-vs-Stage3 |
6.690100E-02 |
Stage2-vs-Stage4 |
1.456200E-02 |
Stage3-vs-Stage4 |
2.224800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.14352971536391E-14 |
Normal-vs-AfricanAmerican |
1.64335212105016E-12 |
Normal-vs-Asian |
2.459000E-03 |
Caucasian-vs-AfricanAmerican |
2.601600E-01 |
Caucasian-vs-Asian |
9.981200E-01 |
AfricanAmerican-vs-Asian |
6.676600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.10782519111308E-15 |
Normal-vs-Female |
1.70785607878088E-12 |
Male-vs-Female |
3.617400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.85764770022479E-12 |
Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(61-80Yrs) |
1.22124532708767E-15 |
Normal-vs-Age(81-100Yrs) |
2.78940004427852E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.990180E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.310200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.815600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.774300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.512400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.887600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.17879999999671E-05 |
Normal-vs-Grade 2 |
5.55111512312578E-15 |
Normal-vs-Grade 3 |
1.11022302462516E-16 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
5.323800E-01 |
Grade 1-vs-Grade 3 |
2.428400E-02 |
Grade 1-vs-Grade 4 |
4.423800E-04 |
Grade 2-vs-Grade 3 |
3.8704000000056E-05 |
Grade 2-vs-Grade 4 |
6.8187999691105E-09 |
Grade 3-vs-Grade 4 |
6.576800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.78923584018776E-12 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
8.143900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.56061879769732E-14 |
Normal-vs-N1 |
8.91060000007826E-07 |
N0-vs-N1 |
2.640400E-01 |
|
|